Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Annual report

4594.TEDINET S100VZBU
Period2024-04-01 → 2025-03-31
Filed2025-06-19
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥1m2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥72,0002023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥5m2022-04-01 → 2023-03-31dStandaloneNet sales (5-year summary)
Revenue¥15m2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥3m2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Operating income−¥1.2bn2024-04-01 → 2025-03-31StandaloneOperating income
Operating income−¥1.2bn2023-04-01 → 2024-03-31StandaloneOperating income
Ordinary income−¥1.1bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income−¥1.2bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income−¥1.5bn2022-04-01 → 2023-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.5bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.1bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Profit before tax−¥1.2bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Net income−¥1.2bn2024-04-01 → 2025-03-31StandaloneProfit loss
Net income−¥1.2bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income−¥1.5bn2022-04-01 → 2023-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.1bnat 2025-03-31StandaloneAssets
Total assets¥1.2bnat 2024-03-31StandaloneAssets
Total assets¥1.7bnat 2023-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.8bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.7bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥196mat 2025-03-31StandaloneLiabilities
Total liabilities¥251mat 2024-03-31StandaloneLiabilities
Net assets / equity¥925mat 2025-03-31StandaloneNet assets
Net assets / equity¥979mat 2024-03-31StandaloneNet assets
Net assets / equity¥1.6bnat 2023-03-31dStandaloneNet assets
Net assets / equity¥2.5bnat 2022-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥3.5bnat 2021-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥810mat 2025-03-31StandaloneCash and deposits
Cash and deposits¥1.1bnat 2024-03-31StandaloneCash and deposits
Cash & equivalents¥810mat 2025-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2023-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.3bnat 2021-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.3bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.8bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥1m2024-04-01 → 2025-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥8m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥2m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥18m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥36m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.0bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥691m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥432m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥569m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥2.1bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-14.122024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.212023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-24.92022-04-01 → 2023-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.552021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.142020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥9.98at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥13.52at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥24.6at 2023-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥45.4at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥69.1at 2021-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio80.6%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.7%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.9%at 2023-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio90.5%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio93.7%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued90,491,300at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued70,741,300at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued62,891,200at 2023-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued55,253,100at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued50,817,500at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees24at 2025-03-31StandaloneNumber of employees
Employees24at 2024-03-31StandaloneNumber of employees
Employees32at 2023-03-31dStandaloneNumber of employees
Employees38at 2022-03-31dStandaloneNumber of employees
Employees44at 2021-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 742
ItemContextValueUnit
Deferred tax liabilitiesPrior1YearInstant_NonConsolidatedMember0JPY
Deferred tax liabilitiesCurrentYearInstant_NonConsolidatedMember0JPY
Provision for retirement benefitsPrior1YearInstant_NonConsolidatedMember37610000JPY
Provision for retirement benefitsCurrentYearInstant_NonConsolidatedMember41221000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember22648000JPY
Asset retirement obligations nclCurrentYearInstant_NonConsolidatedMember22741000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember60258000JPY
Noncurrent liabilitiesCurrentYearInstant_NonConsolidatedMember63962000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember251270000JPY
LiabilitiesCurrentYearInstant_NonConsolidatedMember195624000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember650661000JPY
Capital stockCurrentYearInstant_NonConsolidatedMember1199869000JPY
Legal capital surplusPrior1YearInstant_NonConsolidatedMember550661000JPY
Legal capital surplusCurrentYearInstant_NonConsolidatedMember1099869000JPY
Other capital surplusPrior1YearInstant_NonConsolidatedMember2408534000JPY
Other capital surplusCurrentYearInstant_NonConsolidatedMember2408534000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember2959195000JPY
Capital surplusCurrentYearInstant_NonConsolidatedMember3508404000JPY
Retained earnings brought forwardPrior1YearInstant_NonConsolidatedMember-2653715000JPY
Retained earnings brought forwardCurrentYearInstant_NonConsolidatedMember-3804864000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-2653715000JPY
Retained earningsCurrentYearInstant_NonConsolidatedMember-3804864000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-0JPY
Treasury stockCurrentYearInstant_NonConsolidatedMember-2000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember956141000JPY
Shareholders equityCurrentYearInstant_NonConsolidatedMember903407000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember22845000JPY
Subscription rights to sharesCurrentYearInstant_NonConsolidatedMember21580000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember978987000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember924987000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember1230257000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember1120612000JPY
Net salesPrior1YearDuration_NonConsolidatedMember72000JPY
Net salesCurrentYearDuration_NonConsolidatedMember1133000JPY
Research and development costsPrior1YearDuration_NonConsolidatedMember18000JPY
Research and development costsCurrentYearDuration_NonConsolidatedMember32000JPY
Cost of salesPrior1YearDuration_NonConsolidatedMember18000JPY
Cost of salesCurrentYearDuration_NonConsolidatedMember32000JPY
Gross profitPrior1YearDuration_NonConsolidatedMember54000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember1101000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember1155133000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember1162019000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember-1155078000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember-1160918000JPY
Interest income noiPrior1YearDuration_NonConsolidatedMember12000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember69000JPY
Foreign exchange gains noiPrior1YearDuration_NonConsolidatedMember－JPY
Foreign exchange gains noiCurrentYearDuration_NonConsolidatedMember2245000JPY
Settlement received noiPrior1YearDuration_NonConsolidatedMember－JPY
Settlement received noiCurrentYearDuration_NonConsolidatedMember15108000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-03-31pass
balance sheet identitynon_consolidated 2025-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flownon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass